Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study

Published:2003-06 Issue:2 Volume:15 Page:193-202
ISSN:0169-1112
Container-title:The Pain Clinic
language:en
Short-container-title:The Pain Clinic

Author:

Böhme K.,Likar R.

Publisher

Informa UK Limited

Subject

Anesthesiology and Pain Medicine,Clinical Neurology

Link

http://www.tandfonline.com/doi/pdf/10.1163/156856903321579334

Reference15 articles.

1. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases

2. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study

3. Treatment Principles for the Use of Opioids in Pain of Nonmalignant Origin

4. The Use of Opioids for the Treatment of Chronic Pain*

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opioid analgesics for nociceptive cancer pain: A comprehensive review;CA: A Cancer Journal for Clinicians;2023-12-18

2. High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews;Cochrane Database of Systematic Reviews;2023-03-24

3. Revision of Pharmacological Treatment Recommendations for Cancer Pain: Clinical Guidelines from the Japanese Society of Palliative Medicine;Journal of Palliative Medicine;2022-07-01

4. Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE);Asia-Pacific Journal of Clinical Oncology;2022-05-22

5. Buprenorphine: Mechanism and applications;Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics;2022